Recorded

Billing for Molecular and Genetic Testing: New Trends Impacting Future Reimbursement

Recorded
ABOUT THIS WEBINAR
Is your lab maximizing reimbursement for your molecular and genetic test menu? Thanks to a patchwork of billing and reimbursement guidelines that vary across Medicare Administrative Contractor Jurisdictions and private payers, keeping track of what’s payable and where has historically been a difficult task. But with new proposed rules that could better align billing policy across MAC’s, should we expect more holdouts to enter the MolDX program? Join us as we discuss how to evaluate your proposed test menu to ensure you stay within payer guidelines, and take a look ahead to offer some predictions on how this testing landscape could evolve within the next five to ten years.

During this webinar, we’ll discuss:

• Evaluating your proposed test menu to account for payer/MAC variables when billing for molecular and genetic testing.

• Various MolDX and managed plan requirements for billing these tests. What expectations do labs face for registration or prior authorization in order to be properly paid?

• How newly proposed Local Coverage Determinations (LCD’s) could impact reimbursement in the near future, and what these moves toward conformity could meaning in the coming years.
  • Business & finance
  • Professional development
  • Science & tech
ADDITIONAL INFO
  • Categories:
    • Business & finance
    • Professional development
    • Science & tech
  • When: Eastern Time (US & Canada)
  • Duration: 1 hour
  • Price: Free
  • Language: English
  • Who can attend? Everyone
  • Dial-in available? (listen only): Yes.
  • Dial-in Number: Please register for this Webinar to view the dial-in info.
FEATURED PRESENTERS
HOSTED BY
ATTENDED (194)
  • 1599078637-9c58975edfb37dde
  • -1566584174
  • D
  • J
  • A
  • D
  • 1633435505-4b318b7392bcd9d6
  • S
  • M
  • R
  • B
  • A
  • B
  • N
  • P
  • S
  • N
Share
To invite people, share this page: